Media coverage
1
Media coverage
Title First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome Australian Stock Exchange:MSB.AX Media name/outlet Global English (Middle East and North Africa Financial Network) Country/Territory Jordan Date 6/05/20 Persons Alan Moskowitz, Emilia Bagiella, Annetine Gelijns